Dual-peptide blend: BPC-157 (15-aa pentadecapeptide) + TB-500 (43-aa active fragment of Thymosin Beta-4) The pathways BPC-157 / TB-500 acts on and what each one does
Exact pricing and protocols are confirmed at a personal consultation
That combined approach can address fatigue, repair deficits, and agerelated declines in cellular function in a coordinated way
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including the BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend) research vials, are designated strictly for laboratory research purposes only
declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche